Valion Bio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||
| Net Income | -1.28M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.33M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Share-based CompensationStock Comp. | 0.01M | 0.02M | 0.24M | 1.05M | 0.11M | 0.11M | 0.11M | 0.08M | 0.08M | 0.05M | 0.06M | 0.05M | 0.05M | 0.06M | 0.06M | 0.10M | 0.51M | 0.36M | 0.15M | 0.36M | |
| Asset Writedowns and ImpairmentWritedown | -0.03M | -0.00M | 0.07M | 0.01M | -0.01M | 0.34M | |||||||||||||||
| Change in Working CapitalChange Working Cap. | 0.00M | ||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.04M | -0.00M | -0.00M | 0.03M | -0.00M | -0.03M | -0.04M | 0.12M | 0.02M | -0.10M | -0.05M | -0.01M | 0.06M | -0.06M | 0.01M | ||||||
| Change in InventoryChange Inventory | 0.05M | 0.14M | 0.02M | 0.39M | -0.07M | 0.10M | 0.08M | 0.04M | -0.06M | -0.14M | 0.01M | 0.01M | -0.04M | 0.01M | -0.01M | 0.01M | -0.09M | -16.17M | |||
| Change in Account PayablesChange Payables | 0.52M | 0.12M | -0.51M | -0.16M | 1.29M | -0.31M | -0.28M | -0.23M | -0.26M | -0.19M | 0.07M | -0.17M | -0.10M | -0.11M | -0.21M | 0.31M | -0.20M | 0.23M | -0.20M | ||
| Change in Accured ExpensesChange Accured Exp. | -0.01M | 0.01M | -0.04M | 0.04M | -0.01M | -0.03M | 0.12M | -0.08M | -0.15M | 0.04M | 0.29M | -0.23M | -0.12M | 0.08M | -0.08M | 0.16M | 0.20M | -0.33M | 0.21M | ||
| Cash from OperationsCash from Ops. | -0.54M | -1.64M | -2.76M | -2.20M | -1.72M | -2.78M | -2.22M | -2.43M | -2.47M | -1.84M | -1.77M | -1.70M | -1.30M | -1.40M | -1.32M | -0.90M | -1.82M | -2.00M | -2.29M | ||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.18M | 1.14M | 0.13M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.03M | 0.27M | 0.10M | ||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||||||
| Investing Activities | |||||||||||||||||||||
| Capital ExpendituresCapex | 0.01M | 0.01M | 0.09M | 0.02M | 0.01M | 0.03M | |||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.01M | -0.01M | -0.09M | -0.02M | -0.53M | -0.02M | -0.01M | -0.15M | |||||||||||||
| Financing Activities | |||||||||||||||||||||
| Other financing activitiesOther financing | 0.06M | 0.11M | |||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.57M | 0.87M | 14.89M | -0.58M | 4.17M | -0.04M | 4.38M | -0.06M | 3.31M | -0.10M | 1.18M | 0.08M | 2.36M | 4.27M | 11.63M | ||||||
| Change in Capital Stock | |||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.28M | 0.44M | 0.01M | 0.04M | 339.00 | 0.04M | 0.01M | 0.40M | |||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 4.19M | 4.32M | -3.25M | 0.43M | |||||||||||||||||
| Additional items | |||||||||||||||||||||
| Change in Cash | 1.02M | -0.78M | 12.13M | -2.17M | -1.75M | -2.72M | -2.81M | 1.65M | -2.51M | 2.51M | -1.77M | -1.73M | 2.02M | -1.50M | -0.19M | -1.33M | 0.52M | 2.27M | 9.20M | ||
| Free Cash FlowFCF | -0.54M | -1.64M | -2.76M | -2.21M | -1.72M | -2.79M | -2.22M | -2.52M | -2.50M | -1.84M | -1.77M | -1.70M | -1.30M | -1.40M | -1.32M | -0.90M | -1.82M | -2.01M | -2.31M | ||
| Net Cash FlowNCF | 1.02M | -0.78M | 12.13M | -2.21M | -1.72M | -2.79M | -2.80M | 1.65M | -2.54M | 2.54M | -1.77M | -1.76M | 2.01M | -1.50M | -0.15M | -1.34M | 0.53M | 2.27M | 9.19M |